Transgene SA
0.5740
22-May-25 08:21:37
15 minutes delayed
Stocks
-0.0060
-1.03%
Today's range
0.5460 - 0.5780
ISIN
FR0005175080
Source
Cboe
-
22 May 2025 08:45:00 By Nasdaq GlobeNewswire
-
Transgene's Combined General Meeting of May 15, 2025
15 May 2025 08:45:00 By Nasdaq GlobeNewswire
-
Transgene Provides Business and Financial Update for Q1 2025
24 Apr 2025 08:45:00 By Nasdaq GlobeNewswire
-
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2025
23 Apr 2025 23:00:00 By Nasdaq GlobeNewswire
-
23 Apr 2025 08:45:00 By Nasdaq GlobeNewswire
-
Availability of Transgene’s 2024 Universal Registration Document (URD)
10 Apr 2025 11:15:00 By Nasdaq GlobeNewswire
-
Transgene Appoints Chief Technical Officer (CTO) to Power Future Innovations
01 Apr 2025 08:45:00 By Nasdaq GlobeNewswire
-
27 Mar 2025 09:45:00 By Nasdaq GlobeNewswire
-
Transgene to Participate in Upcoming Investor Meetings
11 Mar 2025 09:45:00 By Nasdaq GlobeNewswire
-
Transgene Shares (Euronext Paris: TNG) Eligible for Inclusion in PEA-PME Accounts
06 Feb 2025 08:45:00 By Nasdaq GlobeNewswire
-
Transgene to Participate in the Biomed Forum Investor Conference
21 Jan 2025 08:45:00 By Nasdaq GlobeNewswire
-
Transgene Announces Financial Calendar for 2025
14 Jan 2025 08:45:00 By Nasdaq GlobeNewswire
-
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024
07 Jan 2025 09:00:00 By Nasdaq GlobeNewswire
-
Transgene Reports Business, Pipeline and Financial Update for Q3 2024
07 Nov 2024 08:45:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 08:45:00 By Nasdaq GlobeNewswire
-
Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
04 Nov 2024 22:30:00 By Nasdaq GlobeNewswire
-
13 Oct 2024 22:30:00 By Nasdaq GlobeNewswire
-
Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024
06 Oct 2024 23:00:00 By Nasdaq GlobeNewswire
-
2024 Half-Year Financial Report
24 Sep 2024 08:45:00 By Nasdaq GlobeNewswire
-
24 Sep 2024 08:45:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >